By Tracey Staton Teva Pharmaceutical Industries is always on the lookout for a good buy. And this time, the Israeli company is looking to build up its women’s health business, scouting about for products to help grow that segment to $1 billion in annual sales. That’s triple what Teva does in that market right now. …
By Maureen Martino Sanofi-Aventis has opened its first R&D center in China, which it hopes will allow it to tap the burgeoning Chinese pharmaceuticals market. The French drugmaker is also pursuing R&D activities in Russia, South Korea and India as part of its ongoing strategy to expand in biologics, generics and emerging markets. R&D chief Marc …
By Tracey Staton Incoming Bristol-Myers Squibb CEO Lamberto Andreotti () certainly has his work cut out for him. As several news outlets have pointed out, job No. 1 will be overcoming the loss of $11 billion in revenue to generic competition by 2016. He’s said that he’s confident BMS can do so, in part by …